Cargando…

Brain MRI correlations with disease burden and biomarkers in Fabry disease

OBJECTIVE: To quantitatively evaluate cerebral small vessel disease (CSVD) in brain magnetic resonance imaging (MRI) and its correlation with disease burden and markers in Fabry disease, a rare X-linked lysosomal storage disease. METHODS: We collected brain MRI data from seventy-one Chinese patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yawen, Zhu, Ying, Li, Fan, Sun, Yunchuang, Ma, Wei, Wu, Yuan, Zhang, Wei, Wang, Zhaoxia, Yuan, Yun, Huang, Yining
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511580/ https://www.ncbi.nlm.nih.gov/pubmed/37356023 http://dx.doi.org/10.1007/s00415-023-11826-8

Ejemplares similares

MRI-visible perivascular spaces as an imaging biomarker in Fabry disease
por: Lyndon, D., et al.
Publicado: (2020)

Investigation of ocular involvement in patients with Fabry disease
por: Wu, Yuan, et al.
Publicado: (2023)

Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients
por: Jiang, Yanyan, et al.
Publicado: (2021)

Cardiac MRI in Fabry disease
por: Umer, Muhammad, et al.
Publicado: (2023)

Oxidative stress biomarkers in Fabry disease: is there a room for them?
por: Simoncini, C., et al.
Publicado: (2020)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Lenticulostriate Arteries and Basal Ganglia Changes in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy, a High-Field MRI Study
por: Ling, Chen, et al.
Publicado: (2019)

Fabry’s Disease: The Utility of a Multidisciplinary Screening Approach
por: Monte, Marco Angelo, et al.
Publicado: (2022)

Increased Serum Interleukin-6 and Tumor Necrosis Factor Alpha Levels in Fabry Disease: Correlation with Disease Burden
por: Rosa, Nilton Salles, et al.
Publicado: (2021)

Parkin is the most common causative gene in a cohort of mainland Chinese patients with sporadic early‐onset Parkinson's disease
por: Jiang, Yanyan, et al.
Publicado: (2020)

The “Black Straight-Line Sign” in the Putamen in Diffusion-Weighted Imaging: A Potential Diagnostic MRI Marker for Multiple System Atrophy
por: Zheng, Yiming, et al.
Publicado: (2022)

Cerebral Hemodynamic Changes to Transcranial Doppler in Asymptomatic Patients with Fabry’s Disease
por: Vagli, Carla, et al.
Publicado: (2020)

Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy
por: Fall, Brent, et al.
Publicado: (2016)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Fabry disease in South and Central Asia: Is it truly a rare disease or underappreciated?
por: Saeed, Sahrai, et al.
Publicado: (2022)

Electrocardiographic Characteristics and Their Correlation with Echocardiographic Alterations in Fabry Disease
por: Zada, Matthew, et al.
Publicado: (2022)

Frequency of de novo mutations in Japanese patients with Fabry disease
por: Kobayashi, Masahisa, et al.
Publicado: (2014)

Basilar artery diameter as neuroimaging biomarker in Chinese Fabry disease patients
por: Lam, Yan Lok Tiffany, et al.
Publicado: (2023)

Anderson-fabry disease: role of traditional and new cardiac MRI techniques
por: Caredda, Gloria, et al.
Publicado: (2021)

Ocular Signs Correlate Well with Disease Severity and Genotype in Fabry Disease
por: Pitz, Susanne, et al.
Publicado: (2015)

Report of cold agglutinins in a patient with acute ischemic stroke
por: Jin, Haiqiang, et al.
Publicado: (2015)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Correlation of retinal vascular characteristics with laboratory and ocular findings in Fabry disease: exploring ocular diagnostic biomarkers
por: Lindziute, Migle, et al.
Publicado: (2023)

Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience
por: Riccio, Eleonora, et al.
Publicado: (2020)

Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease
por: Shu, Liming, et al.
Publicado: (2014)

Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-up
por: Carnicer-Cáceres, Clara, et al.
Publicado: (2021)

Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases
por: Ivanova, Margarita
Publicado: (2020)

Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease
por: Monticelli, Maria, et al.
Publicado: (2023)

Transcatheter Tricuspid Valve Replacement for Anderson Fabry Disease With Severe Tricuspid Regurgitation
por: Zhou, Guang-Wei, et al.
Publicado: (2022)

Structural disconnection and functional reorganization in Fabry disease: a multimodal MRI study
por: Gabusi, Ilaria, et al.
Publicado: (2022)

Sensory-specific peripheral nerve pathology in a rat model of Fabry disease
por: Waltz, Tyler B., et al.
Publicado: (2021)

Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial
por: Schiffmann, Raphael, et al.
Publicado: (2018)

Hypertension in adult Fabry’s disease: is cardiotrophin-1 a diagnostic biomarker?
por: Marazzi, Monica Gioia, et al.
Publicado: (2014)

Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study()()
por: Chimenti, Cristina, et al.
Publicado: (2012)

Genotype–Phenotype Correlation in a New Fabry-Disease-Causing Mutation
por: Čerkauskaitė, Agnė, et al.
Publicado: (2019)

Fabry Disease and Early Stroke
por: Feldt-Rasmussen, U.
Publicado: (2011)

Endoscopic images in Fabry disease
por: Kouvaras, Stergios N.
Publicado: (2012)

Motor involvement in Fabry disease
por: Cocozza, Sirio, et al.
Publicado: (2017)

Hot topics in Fabry disease
por: Cairns, Tereza, et al.
Publicado: (2018)

Fabry disease and incidence of cancer
por: Bird, Sarah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2130cmpo1f0surpkklsj1qf8p8